World Class Health Takes the COE Model Into Specialty Infusion

World Class Health is extending the Centers of Excellence model into one of the most expensive and operationally complex categories in employer healthcare: specialty infusion.

The company announced a new infusion-care offering on September 3 covering 270+ specialty infusions, which World Class Health says represent roughly 95% of commercial infusion spend. The model combines nationwide home infusion with access to hundreds of infusion suites.

For employers already using World Class Health for surgery or imaging, the infusion capability can be activated without a new agreement.

That is what makes this launch notable. It is not just a new specialty vendor. It is another step toward a broader employer purchasing platform that can carve discrete categories of care out of the conventional health-plan pathway.

Why infusion is such a large opportunity

Specialty infusion is unusually sensitive to site of care.

The same drug can carry very different total costs depending on whether it is administered in a hospital outpatient department, physician office, freestanding infusion center or the patient's home. Hospital outpatient settings frequently carry the highest facility and administration costs.

World Class Health says shifting appropriate patients away from hospital outpatient infusion can generate about 46% average savings, or approximately $30,000 to $50,000 annually per redirected patient.

The company says its savings methodology compares the alternative site-of-care cost with a member's prior treatment cost when available, or with a published local outpatient benchmark.

Those are vendor-reported figures, not independently validated savings, but the underlying purchasing logic is important: employers increasingly have the ability to redirect high-cost recurring care to lower-cost settings rather than simply accepting the site and price selected by the traditional network.

The COE model is broadening

Centers of Excellence began largely around high-cost episodic procedures such as orthopedic surgery, cardiac care and complex cancer treatment.

The model is now moving into categories that look very different operationally.

Infusion is recurring rather than episodic. It can involve complex specialty drugs, specialty pharmacy coordination, prior authorization and ongoing clinical administration. That makes it a useful test of whether the COE concept can evolve into a broader direct-purchasing infrastructure for high-cost medical services.

World Class Health already operates across surgery and imaging. Adding infusion creates another employer-accessible category inside the same purchasing platform.

For employers, that can reduce the friction of assembling separate carve-out vendors for every clinical category.

This is also a site-of-care strategy

The launch fits a broader employer trend: use clinical navigation and direct purchasing to move care toward settings with better economics.

For infusion, that may mean moving an eligible member from a hospital outpatient department to the home or an independent infusion suite. For imaging, it may mean redirecting from hospital-based radiology to an independent center. For surgery, it may mean steering toward a bundled provider or Center of Excellence.

The common thread is not a specific clinical specialty. It is active purchasing and steerage around the traditional network's default site and price.

That is becoming a defining feature of the direct-contracting market.

What to watch

The most useful next data points will be employer adoption, covered lives, actual site-of-care migration and independently observable savings.

World Class Health's announced scale — 270+ infusions covering roughly 95% of commercial infusion spend — gives the platform broad theoretical coverage. The more important question is how much employer utilization moves through it.

If employers successfully shift recurring specialty infusion away from high-cost hospital outpatient settings, this category could become one of the clearest examples of how direct purchasing changes the economics of the health plan.

Source

• World Class Health, “World Class Health Launches Infusion Care, Bringing Specialty Drug Treatments Home and Cutting Employer Costs by Roughly 46%,” September 3, 2026.